How The System Helps You Succeed
What’s Included in the System
How Implementation Works
Why A Structured System Matters
Real Practice Outcomes
Creating a Profitable Practice
Patient Demand 
Patient Education 
Staff Education 
Marketing 
Regenerative Medicine Platform
Franchise & PE Support 
Wharton’s Jelly
Exosomes
Anti-Aging
Aesthetic Treatments
Neurological
Autoimmune
Wound Care
Orthopedic Conditions
Clinical Trials
Articles
Research Institutes
5-Amino-1MQ is a small molecule compound that inhibits nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular energy metabolism. NNMT regulates the use of nicotinamide and other methyl donors, influencing NAD+ availability and sirtuin activity.
By inhibiting NNMT, 5-Amino-1MQ has been studied for its ability to enhance energy expenditure, reduce fat mass, and improve insulin sensitivity. It is considered a promising agent in obesity, metabolic, and longevity research, but remains experimental and is not FDA-approved for therapeutic use.
How It Is Used in Research Settings
- Studied for obesity research through fat loss and energy expenditure enhancement.
- Investigated for improving glucose tolerance and insulin sensitivity in type 2 diabetes models.
- Explored for its effects on NAD+ metabolism and sirtuin activation, linking it to healthy aging research.
- Examined in cardiovascular and liver studies for metabolic benefits.
Proposed Uses (Research Areas)
- Obesity and fat metabolism research.
- Type 2 diabetes and insulin resistance studies.
- NAD+ and sirtuin activation research.
- Aging and mitochondrial health studies.
- Cardiovascular and liver disease models.
How It Is Dosed in Research Settings
- Oral (Preclinical Models): Animal studies have used 50–100 mg/kg/day to investigate weight loss and metabolic effects.
- Human data: No standardized clinical dosing established; some experimental protocols use oral capsules in the 25–50 mg/day range.
- Cycle length: Preclinical studies typically last 4–8 weeks; human research remains very limited.
- Handling: Supplied as research powder or capsules; stored in cool, dry conditions per laboratory guidelines.
Important Considerations
- Regulatory status: 5-Amino-1MQ is not FDA-approved; all uses remain experimental.
- Evidence base: Data is mostly from animal models; controlled human trials are scarce.
- Safety: Early research suggests good tolerance in animal models, but potential long-term risks and human safety profile remain unknown.
Disclaimer
This material is provided for educational purposes only and summarizes published research on 5-Amino-1MQ.
It is not medical advice. 5-Amino-1MQ is experimental, not FDA-approved, and should not be viewed as a therapy for medical use.
This compound is for research use only.